Conference abstractPublished 14 Apr 2014
Nanotechnology: Driving the future of development of cardiovascular implants
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Application of nanotechnology, nanocomposite materials and stem cells are a new generation of tools in the development of cardiovascular implants. Their research and development is based on a multidisciplinary team approach from basic science to the clinician. We have developed and patented a family of nanoparticles and nanocomposites materials in the development of organs, and in addition have been using stem cells to enhance organ function. In this talk I will present the development of cardiovascular implants, as well as other organs including trachea using the above materials. I also address our experience in the translation of this technology from the laboratories to the patient, and commercialization of products. Currently we started clinical trial for world first nanocomposite based coronary artery with in-situ endothelization, the transcatheter heart valve and stent are at GLP/GMP preclinical assessment and cardiac patch at early development. In addition, I will also discuss the applications of nanoparticles including fluorescent nanoparticles ?quantum dots? in tracking stem cells
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Alexander Marcus Seifalian”
